Home » Topics » BioWorld Science

BioWorld Science
RSS

miR-31 and miR-3150b predict EGFR TKI efficacy in squamous cell lung carcinoma

April 12, 2018

United Neuroscience announces collaboration to evaluate vaccine candidates for Alzheimer's

April 12, 2018

Zealand, Roche Diabetes Care collaborate in phase III trial of dasiglucagon for CHI

April 12, 2018

FIMECS, Takeda enter license agreement to develop novel immuno-oncology therapies

April 12, 2018

First patient treated in phase Ib/II study of tractinostat in EBV+ lymphoma

April 12, 2018

Evotec and Petra Pharma to apply the INDiGO platform and accelerate Petra-01 development

April 12, 2018

FDA grants fast track to selinexor for the treatment of penta-refractory multiple myeloma

April 11, 2018

A variant in HSD17B13 gene protects from chronic liver disease development

April 11, 2018

European Commission approves Kineret for the treatment of Still's disease

April 11, 2018

Phase III RESOLVE-IT trial reaches target recruitment for the interim analysis cohort

April 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...